News
Our latest moves
All
Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning
Publications
Frontiers in Immunology
April 26, 2021
Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning
Publications
Frontiers in Immunology
April 26, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Announcements
April 26, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Announcements
April 26, 2021
Generative AAV capsid diversification by latent interpolation
Publications
Biorxiv
April 17, 2021
Generative AAV capsid diversification by latent interpolation
Publications
Biorxiv
April 17, 2021
The 20(+1) under 40: Inside the next generation of biotech leaders
Press
Endpoints News
April 6, 2021
The 20(+1) under 40: Inside the next generation of biotech leaders
Press
Endpoints News
April 6, 2021
AI Generates Unprecedented Diversity of AAV Capsids
Press
Gen Eng News
February 12, 2021
AI Generates Unprecedented Diversity of AAV Capsids
Press
Gen Eng News
February 12, 2021
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Press
Stat News
February 11, 2021
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Press
Stat News
February 11, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Announcements
April 26, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Announcements
April 26, 2021
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Announcements
October 14, 2020
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Announcements
October 14, 2020
Xconomy names Dyno Therapeutics 2020 Startup of the Year
Announcements
September 24, 2020
Xconomy names Dyno Therapeutics 2020 Startup of the Year
Announcements
September 24, 2020
Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases
Announcements
May 11, 2020
Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases
Announcements
May 11, 2020
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy using Artificial Intelligence
Announcements
May 11, 2020
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy using Artificial Intelligence
Announcements
May 11, 2020
Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology
Announcements
May 11, 2020
Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology
Announcements
May 11, 2020
Dyno Therapeutics announces publication in Nature Biotechnology demonstrating use of artificial intelligence to generate unprecedented diversity of AAV capsids and broaden reach of gene therapies
Announcements
February 11, 2020
Dyno Therapeutics announces publication in Nature Biotechnology demonstrating use of artificial intelligence to generate unprecedented diversity of AAV capsids and broaden reach of gene therapies
Announcements
February 11, 2020
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Deep diversification of an AAV capsid protein by machine learning
Publications
Nature Biotechnology
February 11, 2021
Deep diversification of an AAV capsid protein by machine learning
Publications
Nature Biotechnology
February 11, 2021
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
A primer on model-guided exploration of fitness landscapes for biological sequence design
Publications
Arxiv
October 4, 2020
A primer on model-guided exploration of fitness landscapes for biological sequence design
Publications
Arxiv
October 4, 2020
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Publications
Science
November 29, 2019
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Publications
Science
November 29, 2019
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home
Press
Endpoints News
September 22, 2021
The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home
Press
Endpoints News
September 22, 2021
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Press
Business Insider
August 2, 2021
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Press
Business Insider
August 2, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021